Saint Alphonsus Regional Medical Center Report issue

Academic/Hospital Phase 3

Organization Overview

First Clinical Trial
2018
NCT04441112
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2018

Timeline

NOW
  • Now

Alternative names

Saint Alphonsus Regional Medical Center | Student Investigator at Saint Alphonsus Regional Medical Center | Surgeon at Saint Alphonsus Regional Medical Center

Active Ingredients

Drugs in Phase 3 Trials (2)

ketorolac (acuvail) (1 trial)

triamcinolone (kenalog) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Arthritis (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 1
  • # of Trial APIs: 2